Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis

Published:2016-12-01 Issue:7 Volume:64 Page:e26375
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Ananth Prasanna¹,Werger Annette¹,Voss Stephan²,Rodriguez-Galindo Carlos³,Janeway Katherine A.¹

Affiliation:

1. Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Boston Massachusetts

2. Department of Radiology; Boston Children's Hospital; Boston Massachusetts

3. Department of Global Pediatric Medicine, St. Jude Children's Research Hospital; Memphis Tennessee

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference19 articles.

1. Multimodality treatment of mesenteric desmoid tumours;Bertagnolli;Eur J Cancer,2008

2. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up;Penel;Ann Oncol,2011

3. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis;Constantinidou;Eur J Cancer,2009

4. The treatment of desmoid tumors: a stepwise clinical approach;Bonvalot;Ann Oncol,2012

5. Desmoid tumors: a novel approach for local control;Baliski;J Surg Oncol,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors;Pediatric Drugs;2022-07-29

2. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review;MUSCULOSKELETAL SURGERY;2022-02-12

3. Management of aggressive fibromatosis (Review);Oncology Letters;2020-11-17

4. Safety and efficacy of gamma‐secretase inhibitor nirogacestat (PF‐03084014) in desmoid tumor: Report of four pediatric/young adult cases;Pediatric Blood & Cancer;2020-08-06

5. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review;Japanese Journal of Clinical Oncology;2020-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3